These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10843300)

  • 1. Treatment of heroin-dependent poly-drug abusers with contingency management and buprenorphine maintenance.
    Downey KK; Helmus TC; Schuster CR
    Exp Clin Psychopharmacol; 2000 May; 8(2):176-84. PubMed ID: 10843300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial.
    George TP; Chawarski MC; Pakes J; Carroll KM; Kosten TR; Schottenfeld RS
    Biol Psychiatry; 2000 Jun; 47(12):1080-6. PubMed ID: 10862808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone and buprenorphine combination in the treatment of opioid dependence.
    Gerra G; Fantoma A; Zaimovic A
    J Psychopharmacol; 2006 Nov; 20(6):806-14. PubMed ID: 16401652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.
    O'Connor PG; Oliveto AH; Shi JM; Triffleman EG; Carroll KM; Kosten TR; Rounsaville BJ; Pakes JA; Schottenfeld RS
    Am J Med; 1998 Aug; 105(2):100-5. PubMed ID: 9727815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voucher reinforcement for heroin and cocaine abstinence in an outpatient drug-free program.
    Katz EC; Chutuape MA; Jones HE; Stitzer ML
    Exp Clin Psychopharmacol; 2002 May; 10(2):136-43. PubMed ID: 12022799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population.
    Poling J; Oliveto A; Petry N; Sofuoglu M; Gonsai K; Gonzalez G; Martell B; Kosten TR
    Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained cocaine abstinence in methadone maintenance patients through voucher-based reinforcement therapy.
    Silverman K; Higgins ST; Brooner RK; Montoya ID; Cone EJ; Schuster CR; Preston KL
    Arch Gen Psychiatry; 1996 May; 53(5):409-15. PubMed ID: 8624184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrice-weekly versus daily buprenorphine maintenance.
    Schottenfeld RS; Pakes J; O'Connor P; Chawarski M; Oliveto A; Kosten TR
    Biol Psychiatry; 2000 Jun; 47(12):1072-9. PubMed ID: 10862807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy.
    Messinis L; Lyros E; Andrian V; Katsakiori P; Panagis G; Georgiou V; Papathanasopoulos P
    Hum Psychopharmacol; 2009 Oct; 24(7):524-31. PubMed ID: 19650155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial comparing two treatment strategies using prize-based reinforcement of abstinence in cocaine and opiate users.
    Preston KL; Ghitza UE; Schmittner JP; Schroeder JR; Epstein DH
    J Appl Behav Anal; 2008; 41(4):551-63. PubMed ID: 19192859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.
    Dürsteler-MacFarland KM; Farronato NS; Strasser J; Boss J; Kuntze MF; Petitjean SA; Bürki C; Wiesbeck GA
    J Clin Psychopharmacol; 2013 Feb; 33(1):104-8. PubMed ID: 23277248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single- versus dual-drug target: effects in a brief abstinence incentive procedure.
    Correia CJ; Dallery J; Katz EC; Silverman K; Bigelow G; Stitzer ML
    Exp Clin Psychopharmacol; 2003 Nov; 11(4):302-8. PubMed ID: 14599264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine from detox and beyond: preliminary evaluation of a pilot program to increase heroin dependent individuals' engagement in a full continuum of care.
    Donovan DM; Knox PC; Skytta JA; Blayney JA; DiCenzo J
    J Subst Abuse Treat; 2013 Apr; 44(4):426-32. PubMed ID: 23007109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.